Osimertinib in EGFR-Mutated Lung Cancer. Reply
- PMID: 33596365
- DOI: 10.1056/NEJMc2033951
Osimertinib in EGFR-Mutated Lung Cancer. Reply
Comment on
-
Osimertinib in EGFR-Mutated Lung Cancer.N Engl J Med. 2021 Feb 18;384(7):675. doi: 10.1056/NEJMc2033951. N Engl J Med. 2021. PMID: 33596364 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous